Peter J. Whitehouse, MD, PhD - Publications

Affiliations: 
Neurology Case Western Reserve University, Cleveland Heights, OH, United States 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=116
Website:
http://www.peterwhitehouse.com/

251 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Whitehouse PJ, George DR. A Tale of Two Reports: What Recent Publications from the Alzheimer's Association and Institute of Medicine say about the State of the Field. Journal of Alzheimer's Disease : Jad. 49: 21-5. PMID 26444797 DOI: 10.3233/JAD-150663  0.92
2014 George DR, Whitehouse PJ. Public Justice: Emphasizing the Social in Health and the Health in Social. International Journal of Aging & Human Development. 80: 95-8. PMID 26215303 DOI: 10.1177/0091415015591114  0.92
2014 Whitehouse PJ, Sykes K, George DR. Ecological Change and Aging: A Need to Think Deeply and Act Quickly. International Journal of Aging & Human Development. 80: 3-9. PMID 26215295 DOI: 10.1177/0091415015591106  0.92
2014 Green RC, Christensen KD, Cupples LA, Relkin NR, Whitehouse PJ, Royal CD, Obisesan TO, Cook-Deegan R, Linnenbringer E, Butson MB, Fasaye G, Levinson E, Roberts JS. A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25499536 DOI: 10.1016/j.jalz.2014.10.014  0.92
2014 Zhu CW, Sano M, Ferris SH, Whitehouse PJ, Patterson MB, Galasko D, Schneider LS, Aisen PS. Alzheimer's Disease Cooperative Study Prevention Instrument Project assessing resource use and volunteer and paid work in healthy elders: a longitudinal study. Journal of the American Geriatrics Society. 62: 985-8. PMID 24828933 DOI: 10.1111/jgs.12816  0.92
2014 George DR, Whitehouse PJ. Chasing the "white whale" of Alzheimer's. Journal of the American Geriatrics Society. 62: 588-9. PMID 24628643 DOI: 10.1111/jgs.12713  0.92
2014 George DR, Whitehouse PJ. The War (on Terror) on Alzheimer's. Dementia (London, England). 13: 120-30. PMID 24381043 DOI: 10.1177/1471301212451382  0.92
2014 Whitehouse PJ. The end of Alzheimer's disease--from biochemical pharmacology to ecopsychosociology: a personal perspective. Biochemical Pharmacology. 88: 677-81. PMID 24304687 DOI: 10.1016/j.bcp.2013.11.017  0.92
2013 Zhu CW, Sano M, Ferris SH, Whitehouse PJ, Patterson MB, Aisen PS. Health-related resource use and costs in elderly adults with and without mild cognitive impairment. Journal of the American Geriatrics Society. 61: 396-402. PMID 23414481 DOI: 10.1111/jgs.12132  0.92
2013 George DR, Qualls SH, Camp CJ, Whitehouse PJ. Renovating Alzheimer's: "constructive" reflections on the new clinical and research diagnostic guidelines. The Gerontologist. 53: 378-87. PMID 22936533 DOI: 10.1093/geront/gns096  0.92
2012 George DR, Whitehouse PJ, D'Alton S, Ballenger J. Through the amyloid gateway. Lancet. 380: 1986-7. PMID 23236607 DOI: 10.1016/S0140-6736(12)62145-X  0.92
2012 George DR, Whitehouse PJ, Harris D. "Occupy nature": passing activism across generations. Journal of the American Geriatrics Society. 60: 1770-1. PMID 22985147 DOI: 10.1111/j.1532-5415.2012.04110.x  0.92
2012 Whitehouse PJ. A clinical neuroscientist looks neuroskeptically at neuroethics in the neuroworld The Neuroscientific Turn: Transdisciplinarity in the Age of the Brain. 2147483647: 199-215.  0.92
2011 Whitehouse PJ, George D. Further limits on labels for cognitive impairment: can we diagnose what we don't know? The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 19: 984. PMID 21937918 DOI: 10.1097/JGP.0b013e3182330fef  0.92
2011 Whitehouse PJ, George DR. Uncertain progress on the fuzzy boundaries of Alzheimer's disease: reading between the guidelines. Journal of Alzheimer's Disease : Jad. 26: 1-5. PMID 21743133 DOI: 10.3233/JAD-2011-111020  0.92
2011 George DR, Whitehouse PJ, Ballenger J. The evolving classification of dementia: placing the DSM-V in a meaningful historical and cultural context and pondering the future of "Alzheimer's". Culture, Medicine and Psychiatry. 35: 417-35. PMID 21594753 DOI: 10.1007/s11013-011-9219-x  0.92
2011 George DR, Whitehouse PJ. Marketplace of memory: what the brain fitness technology industry says about us and how we can do better. The Gerontologist. 51: 590-6. PMID 21572161 DOI: 10.1093/geront/gnr042  0.92
2011 Whitehouse PJ, George DR, D'Alton S. Describing the dying days of "Alzheimer's disease". Journal of Alzheimer's Disease : Jad. 24: 11-3. PMID 21187588 DOI: 10.3233/JAD-2010-101639  0.92
2011 Miyamoto M, George DR, Whitehouse PJ. Government, professional and public efforts in japan to change the designation of dementia (chihō) Dementia. 10: 475-486. DOI: 10.1177/1471301211416616  0.92
2010 Dangour AD, Whitehouse PJ, Rafferty K, Mitchell SA, Smith L, Hawkesworth S, Vellas B. B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review. Journal of Alzheimer's Disease : Jad. 22: 205-24. PMID 20847412 DOI: 10.3233/JAD-2010-090940  0.92
2010 Vayda SE, Patterson MB, Whitehouse PJ. The future of dementia: a case of hardening of the categories. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 18: 755-8. PMID 20808144 DOI: 10.1097/JGP.0b013e3181eb5a8b  0.92
2010 George DR, Whitehouse PJ. Intergenerational volunteering and quality of life for persons with mild-to-moderate dementia: results from a 5-month intervention study in the United States. Journal of the American Geriatrics Society. 58: 796-7. PMID 20398169 DOI: 10.1111/j.1532-5415.2010.02790.x  0.92
2010 Whitehouse PJ, George D. Protecting life and lives: putting gene research in context. Journal of Alzheimer's Disease : Jad. 20: 415-6. PMID 20182033 DOI: 10.3233/JAD-2010-091424  0.92
2010 Whitehouse PJ. Dementia: Alzheimer's Encyclopedia of Gerontology. 374-379. DOI: 10.1016/B0-12-370870-2/00049-4  0.92
2009 Fotuhi M, Hachinski V, Whitehouse PJ. Changing perspectives regarding late-life dementia. Nature Reviews. Neurology. 5: 649-58. PMID 19918254 DOI: 10.1038/nrneurol.2009.175  0.92
2009 George DR, Dangour AD, Smith L, Ruddick J, Vellas B, Whitehouse PJ. The role of nutrients in the prevention and treatment of Alzheimer's disease: methodology for a systematic review. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 16: 8-11. PMID 19703214 DOI: 10.1111/j.1468-1331.2009.02736.x  0.92
2009 Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, Eckert SL, Butson M, Sadovnick AD, Quaid KA, Chen C, Cook-Deegan R, Farrer LA. Disclosure of APOE genotype for risk of Alzheimer's disease. The New England Journal of Medicine. 361: 245-54. PMID 19605829 DOI: 10.1056/NEJMoa0809578  0.92
2009 Whitehouse PJ, George D. Banking on stories for healthier cognitive ageing. Lancet. 373: 1166-7. PMID 19350706 DOI: 10.1016/S0140-6736(09)60672-3  0.92
2008 Stocking CB, Hougham GW, Danner DD, Patterson MB, Whitehouse PJ, Sachs GA. Variable judgments of decisional capacity in cognitively impaired research subjects. Journal of the American Geriatrics Society. 56: 1893-7. PMID 19054202 DOI: 10.1111/j.1532-5415.2008.01922.x  0.92
2008 Whitehouse PJ, Sami SA. Quality of life in dementias. Handbook of Clinical Neurology. 89: 97-100. PMID 18631734 DOI: 10.1016/S0072-9752(07)01208-0  0.92
2008 Whitehouse PJ. National Institute of Health and Clinical Excellence decision processes supported by UK High Court: the debate about the value of Alzheimer's disease drugs continues. Journal of Alzheimer's Disease : Jad. 13: 239-40. PMID 18567175  0.92
2008 Dawson NV, Singer ME, Lenert L, Patterson MB, Sami SA, Gonsenhouser I, Lindstrom HA, Smyth KA, Barber MJ, Whitehouse PJ. Health state valuation in mild to moderate cognitive impairment: feasibility of computer-based, direct patient utility assessment. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 28: 220-32. PMID 18349434 DOI: 10.1177/0272989X07311750  0.92
2008 Christensen KD, Roberts JS, Royal CD, Fasaye GA, Obisesan T, Cupples LA, Whitehouse PJ, Butson MB, Linnenbringer E, Relkin NR, Farrer L, Cook-Deegan R, Green RC. Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 10: 207-14. PMID 18344711 DOI: 10.1097/GIM.0b013e318164e4cf  0.92
2008 Whitehouse PJ. Why I no longer consult for drug companies. Culture, Medicine and Psychiatry. 32: 4-10. PMID 18181012 DOI: 10.1007/s11013-007-9075-x  0.92
2008 Campbell KH, Stocking CB, Hougham GW, Whitehouse PJ, Danner DD, Sachs GA. Dementia, diagnostic disclosure, and self-reported health status. Journal of the American Geriatrics Society. 56: 296-300. PMID 18179491 DOI: 10.1111/j.1532-5415.2007.01551.x  0.92
2007 Stocking CB, Hougham GW, Danner DD, Patterson MB, Whitehouse PJ, Sachs GA. Empirical assessment of a research advance directive for persons with dementia and their proxies. Journal of the American Geriatrics Society. 55: 1609-12. PMID 17714461 DOI: 10.1111/j.1532-5415.2007.01318.x  0.92
2007 Whitehouse PJ, Waller S. Involuntary emotional expressive disorder: a case for a deeper neuroethics. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 4: 560-7. PMID 17599723 DOI: 10.1016/j.nurt.2007.03.003  0.92
2007 Whitehouse PJ. Commentary: integrative narrative evolutionary health: toward a wiser view of Alzheimer's disease. Journal of Alternative and Complementary Medicine (New York, N.Y.). 13: 341-4. PMID 17480133 DOI: 10.1089/acm.2006.6404  0.92
2007 Whitehouse PJ. Mild cognitive impairment--a confused concept? Nature Clinical Practice. Neurology. 3: 62-3. PMID 17279077 DOI: 10.1038/ncpneuro0403  0.92
2007 Whitehouse PJ. In response [3] Alzheimer Disease and Associated Disorders. 21: 266-267. DOI: 10.1097/WAD.0b013e3181451f58  0.92
2006 Eckert SL, Katzen H, Roberts JS, Barber M, Ravdin LD, Relkin NR, Whitehouse PJ, Green RC. Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 8: 746-51. PMID 17172937 DOI: 10.1097/01.gim.0000250197.44245.a3  0.92
2006 Whitehouse PJ, Rajcan JL, Sami SA, Patterson MB, Smyth KA, Edland SD, George DR. ADCS Prevention Instrument Project: pilot testing of a book club as a psychosocial intervention and recruitment and retention strategy. Alzheimer Disease and Associated Disorders. 20: S203-8. PMID 17135813 DOI: 10.1097/01.wad.0000213876.70794.c6  0.92
2006 Sano M, Zhu CW, Whitehouse PJ, Edland S, Jin S, Ernstrom K, Thomas RG, Thal LJ, Ferris SH. ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly. Alzheimer Disease and Associated Disorders. 20: S191-202. PMID 17135812 DOI: 10.1097/01.wad.0000213875.63171.87  0.92
2006 Patterson MB, Whitehouse PJ, Edland SD, Sami SA, Sano M, Smyth K, Weiner MF. ADCS Prevention Instrument Project: quality of life assessment (QOL). Alzheimer Disease and Associated Disorders. 20: S179-90. PMID 17135811 DOI: 10.1097/01.wad.0000213874.25053.e5  0.92
2006 Ferris SH, Aisen PS, Cummings J, Galasko D, Salmon DP, Schneider L, Sano M, Whitehouse PJ, Edland S, Thal LJ. ADCS Prevention Instrument Project: overview and initial results. Alzheimer Disease and Associated Disorders. 20: S109-23. PMID 17135805 DOI: 10.1097/01.wad.0000213870.40300.21  0.92
2006 Whitehouse PJ. The end of AD. Part 3. Alzheimer Disease and Associated Disorders. 20: 195-8. PMID 17132959 DOI: 10.1097/01.wad.0000213864.02182.f7  0.92
2006 Whitehouse PJ. Quality of life: the bridge from the cholinergic basal forebrain to cognitive science and bioethics. Journal of Alzheimer's Disease : Jad. 9: 447-53. PMID 16914884  0.92
2006 Stocking CB, Hougham GW, Danner DD, Patterson MB, Whitehouse PJ, Sachs GA. Speaking of research advance directives: planning for future research participation. Neurology. 66: 1361-6. PMID 16682668 DOI: 10.1212/01.wnl.0000216424.66098.55  0.92
2005 Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Green RC. Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study. Journal of Geriatric Psychiatry and Neurology. 18: 250-5. PMID 16306249 DOI: 10.1177/0891988705281883  0.92
2005 Whitehouse PJ, Juengst ET. Antiaging medicine and mild cognitive impairment: practice and policy issues for geriatrics. Journal of the American Geriatrics Society. 53: 1417-22. PMID 16078972 DOI: 10.1111/j.1532-5415.2005.53411.x  0.92
2005 Whitehouse PJ, Gaines AD, Lindstrom H, Graham JE. Anthropological contributions to the understanding of age-related cognitive impairment. The Lancet. Neurology. 4: 320-6. PMID 15847845 DOI: 10.1016/S1474-4422(05)70075-2  0.92
2005 Whitehouse PJ, Whitehouse CC. The intergenerational school: Integrating intergenerational approaches in the care of those with age-related cognitive challenges Australasian Journal On Ageing. 24: S57-S58. DOI: 10.1111/j.1741-6612.2005.00092.x  0.92
2004 Whitehouse PJ. Regulatory aspects of mild cognitive impairment: toward a harmonized perspective. Dialogues in Clinical Neuroscience. 6: 409-14. PMID 22033834  0.92
2004 Roberts JS, Barber M, Brown TM, Cupples LA, Farrer LA, LaRusse SA, Post SG, Quaid KA, Ravdin LD, Relkin NR, Sadovnick AD, Whitehouse PJ, Woodard JL, Green RC. Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 6: 197-203. PMID 15266207 DOI: 10.1097/01.GIM.0000132688.55591.77  0.92
2004 Lee JH, Friedland R, Whitehouse PJ, Woo JI. Twenty-four-hour rhythms of sleep-wake cycle and temperature in Alzheimer's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 16: 192-8. PMID 15260371 DOI: 10.1176/appi.neuropsych.16.2.192  0.92
2004 Mehlman MJ, Binstock RH, Juengst ET, Ponsaran RS, Whitehouse PJ. Anti-aging medicine: can consumers be better protected? The Gerontologist. 44: 304-10. PMID 15197284  0.92
2004 Whitehouse PJ, Fishman JR. Justice and the house of medicine: the mortgaging of ecology and economics. The American Journal of Bioethics : Ajob. 4: 43-5. PMID 15186692 DOI: 10.1162/152651604323097772  0.92
2004 Whitehouse PJ. Paying attention to acetylcholine: the key to wisdom and quality of life? Progress in Brain Research. 145: 311-7. PMID 14650925 DOI: 10.1016/S0079-6123(03)45022-X  0.92
2003 Hougham GW, Sachs GA, Danner D, Mintz J, Patterson M, Roberts LW, Siminoff LA, Sugarman J, Whitehouse PJ, Wirshing D. Empirical research on informed consent with the cognitively impaired. Irb. S26-S32. PMID 14870736  0.92
2003 Whitehouse PJ. The rebirth of bioethics: extending the original formulations of Van Rensselaer Potter. The American Journal of Bioethics : Ajob. 3: W26-W31. PMID 14744319 DOI: 10.1162/152651603322614751  0.92
2003 Whitehouse PJ, Patterson MB, Sami SA. Quality of life in dementia: ten years later. Alzheimer Disease and Associated Disorders. 17: 199-200. PMID 14657782 DOI: 10.1097/00002093-200310000-00001  0.92
2003 Connemann BJ, Mumenthaler MS, Yesavage JA, Taylor JL, Friedman L, O'Hara R, Sheikh J, Tinklenberg J, Whitehouse PJ. Donepezil and flight simulator performance: Effects on retention of complex skills [1] (multiple letters) Neurology. 61: 721. PMID 12963782  0.92
2003 Whitehouse PJ. MSJAMA: Lessons and responses in Alzheimer disease research. Jama. 290: 115. PMID 12837723 DOI: 10.1001/jama.290.1.115  0.92
2003 Whitehouse PJ. Research advances in the neurology of dementia. Alzheimer Disease and Associated Disorders. 17: 127-8. PMID 12794391 DOI: 10.1097/00002093-200304000-00012  0.92
2003 Roberts JS, LaRusse SA, Katzen H, Whitehouse PJ, Barber M, Post SG, Relkin N, Quaid K, Pietrzak RH, Cupples LA, Farrer LA, Brown T, Green RC. Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease. Alzheimer Disease and Associated Disorders. 17: 86-93. PMID 12794385 DOI: 10.1097/00002093-200304000-00006  0.92
2003 Whitehouse PJ, Arai H, Matsui T, Maruyama M, Okamura N, Sasaki H. Classification of dementias [9] (multiple letters) Lancet. 361: 1227-1228. PMID 12686070 DOI: 10.1016/S0140-6736(03)12938-8  0.92
2003 Whitehouse PJ. Classification of the dementias. Lancet. 361: 1227. PMID 12686069 DOI: 10.1016/S0140-6736(03)12937-6  0.92
2003 Szatmari SZ, Whitehouse PJ. Vinpocetine for cognitive impairment and dementia. The Cochrane Database of Systematic Reviews. CD003119. PMID 12535455 DOI: 10.1002/14651858.CD003119  0.92
2002 Barber M, Whitehouse PJ. Susceptibility testing for Alzheimer's disease: race for the future. The Lancet. Neurology. 1: 10. PMID 12849539 DOI: 10.1016/S1474-4422(02)00009-1  0.92
2002 Karlawish JH, Knopman D, Clark CM, Morris JC, Marson D, Whitehouse PJ, Kawas CH. Informed consent for Alzheimer's disease clinical trials: a survey of clinical investigators. Irb. 24: 1-5. PMID 12737167  0.92
2002 Whitehouse PJ. Van Rensselaer Potter: an intellectual memoir. Cambridge Quarterly of Healthcare Ethics : Cq : the International Journal of Healthcare Ethics Committees. 11: 331-4. PMID 12360702  0.92
2002 Whitehouse PJ. The evolution of gene patenting. The American Journal of Bioethics : Ajob. 2: 23-4. PMID 12230849 DOI: 10.1162/152651602760250057  0.92
2002 Yesavage JA, Mumenthaler MS, Taylor JL, Friedman L, O'Hara R, Sheikh J, Tinklenberg J, Whitehouse PJ. Donepezil and flight simulator performance: effects on retention of complex skills. Neurology. 59: 123-5. PMID 12105320  0.92
2001 Whitehouse PJ. The end of Alzheimer disease II: commentary on "Decisions to treat or not to treat pneumonia in demented psychogeriatric nursing home patients". Alzheimer Disease and Associated Disorders. 15: 118. PMID 11522928 DOI: 10.1097/00002093-200107000-00002  0.92
2001 Mack JL, Whitehouse PJ. Quality of Life in Dementia: state of the art--report of the International Working Group for Harmonization of Dementia Drug Guidelines and the Alzheimer's Society satellite meeting. Alzheimer Disease and Associated Disorders. 15: 69-71. PMID 11403334 DOI: 10.1097/00002093-200104000-00005  0.92
2001 Whitehouse PJ. The end of Alzheimer disease. Alzheimer Disease and Associated Disorders. 15: 59-62. PMID 11403331 DOI: 10.1097/00002093-200104000-00001  0.92
2001 Post SG, Stuckey JC, Whitehouse PJ, Ollerton S, Durkin C, Robbins D, Fallcreek SJ. A focus group on cognition-enhancing medications in Alzheimer disease: disparities between professionals and consumers. Alzheimer Disease and Associated Disorders. 15: 80-8. PMID 11391089 DOI: 10.1097/00002093-200104000-00007  0.92
2001 Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 56: 1154-66. PMID 11342679  0.92
2001 Whitehouse PJ. Editorial commentary Alzheimer Disease and Associated Disorders. 15: 63.  0.92
2001 Brummel-Smith K, Busby-Whitehead J, Reuben D, Tinetti ME, Whitehouse PJ, Katz PR, Potter JF, Semla TP, Johnson JC. Minutes of the members' business meeting Journal of the American Geriatrics Society. 49: 485-486.  0.92
2000 Whitehouse PJ. New models for a new age. Alzheimer Disease and Associated Disorders. 14: 59. PMID 10850742 DOI: 10.1097/00002093-200004000-00001  0.92
2000 Whitehouse PJ. Harmonization of Dementia Drug Guidelines (United States and Europe): a report of the International Working Group for the Harmonization for Dementia Drug Guidelines. Alzheimer Disease and Associated Disorders. 14: S119-22. PMID 10850740 DOI: 10.1097/00002093-200000001-00018  0.92
2000 Whitehouse PJ, Bendezu E, FallCreek S, Whitehouse C. Intergenerational community schools: A new practice for a new time Educational Gerontology. 26: 761-770.  0.92
2000 Woods DC, Patterson MB, Whitehouse PJ. Utility of the Judgment Questionnaire subtest of the Neurobehavioral Cognitive Status Examination in the evaluation of individuals with Alzheimer's Disease Clinical Gerontologist. 21: 49-66.  0.92
2000 Whitehouse PJ. Alzheimer disease and associated disorders: Editorial commentary Alzheimer Disease and Associated Disorders. 14: 127.  0.92
2000 Whitehouse PJ. Regulatory issues concerning behavioral and psychological symptoms of dementia: An overview International Psychogeriatrics. 12: 317-320.  0.92
1999 Whitehouse PJ. Alzheimer's disease: past, present, and future. European Archives of Psychiatry and Clinical Neuroscience. 249: 43-5. PMID 10654099  0.92
1999 Jobst KA, Shostak D, Whitehouse PJ. Diseases of meaning, manifestations of health, and metaphor. Journal of Alternative and Complementary Medicine (New York, N.Y.). 5: 495-502. PMID 10630342  0.92
1999 Erkinjuntti T, Sawada T, Whitehouse PJ. The Osaka Conference on Vascular Dementia 1998. Alzheimer Disease and Associated Disorders. 13: S1-3. PMID 10609674  0.92
1999 Hinze SW, Gaines AD, Lerner AJ, Whitehouse PJ. An interdisciplinary response to the Reagan Research Institute Report on Women and Alzheimer's Disease. Alzheimer Disease and Associated Disorders. 13: 183-6. PMID 10609665  0.92
1999 Ballenger JF, Nelson JL, Whitehouse PJ. Beyond "progress" in the history of Alzheimer disease. Alzheimer Disease and Associated Disorders. 13: 130-1. PMID 10485570  0.92
1999 Kawas CH, Clark CM, Farlow MR, Knopman DS, Marson D, Morris JC, Thal LJ, Whitehouse PJ. Clinical trials in Alzheimer disease: debate on the use of placebo controls. Alzheimer Disease and Associated Disorders. 13: 124-9. PMID 10485569  0.92
1999 Whitehouse PJ, Arizaga R, Brodaty H, Gauthier S, Graham N, Green RC, Homma A, Mangone C, Senanarong V, Xu XH. Placebos in clinical trials in Alzheimer disease: an international discussion. Alzheimer Disease and Associated Disorders. 13: 121-3. PMID 10485568  0.92
1999 Bianchetti A, Trabucchi M, Whitehouse PJ, Post SG. Ethical problems in the use of antidementia drugs [2] (multiple letters) Journal of the American Geriatrics Society. 47: 913. PMID 10404943  0.92
1999 Post SG, Whitehouse PJ. Spirituality, religion, and Alzheimer's disease. Journal of Health Care Chaplaincy. 8: 45-57. PMID 10387591  0.92
1999 Brodaty H, Dresser R, Eisner M, Erkunjuntti T, Gauthier S, Graham N, Jonker C, Sachs G, Whitehouse PJ. Alzheimer's Disease International and International Working Group for Harmonization of Dementia Drug Guidelines for research involving human subjects with dementia Alzheimer Disease and Associated Disorders. 13: 71-79. PMID 10372949  0.92
1999 Cohen CA, Whitehouse PJ, Post SG, Gauthier S, Eberhart A, LeDuc L. Ethical issues in Alzheimer disease: the experience of a national Alzheimer society task force. Alzheimer Disease and Associated Disorders. 13: 66-70. PMID 10372948  0.92
1999 Post SG, Whitehouse PJ, Nelson JL, Sachs GA. Alzheimer disease ethics: a continuing area of public interest. Alzheimer Disease and Associated Disorders. 13: 63-5. PMID 10372947  0.92
1999 Whitehouse PJ. Interesting conflicts and conflicting interests. Journal of the American Geriatrics Society. 47: 759-61. PMID 10366182  0.92
1999 Whitehouse PJ. Managed care and complementary and alternative medicine: lessons from the past and suggestions for the future. Journal of Alternative and Complementary Medicine (New York, N.Y.). 5: 1-2. PMID 10100027  0.92
1999 Whitehouse PJ. The ecomedical disconnection syndrome. The Hastings Center Report. 29: 41-4. PMID 10052011  0.92
1999 Whitehouse PJ, Post SG. In reply Journal of the American Geriatrics Society. 47: 913. DOI: 10.1111/j.1532-5415.1999.tb03857.x  0.92
1999 Whitehouse PJ. Cholinesterase inhibitors in Alzheimer's disease: Are they worth the cost? Cns Drugs. 11: 167-173.  0.92
1998 Whitehouse PJ. Donepezil. Drugs of Today (Barcelona, Spain : 1998). 34: 321-6. PMID 15010720  0.92
1998 Gaines AD, Whitehouse PJ. Harmony and consensus: cultural aspects of organization in international science. Alzheimer Disease and Associated Disorders. 12: 295-301. PMID 9876957  0.92
1998 Whitehouse PJ, Kittner B, Roessner M, Rossor M, Sano M, Thal L, Winblad B. Clinical trial designs for demonstrating disease-course-altering effects in dementia. Alzheimer Disease and Associated Disorders. 12: 281-94. PMID 9876956  0.92
1998 Whitehouse PJ, Winblad B, Shostak D, Bhattacharjya A, Brod M, Brodaty H, Dor A, Feldman H, Forette F, Gauthier S, Hay J, Henke C, Hill S, Mastey V, Neumann P, et al. First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary. Alzheimer Disease and Associated Disorders. 12: 266-80. PMID 9876955  0.92
1998 Doody R, Whitehouse PJ, Chen Q, Wang L, Wu Q, Rosser M, Xu XH. Alzheimer disease-related activities in China: a report from the International Working Group on the Harmonization of Dementia Drug Guidelines. Alzheimer Disease and Associated Disorders. 12: 263-5. PMID 9876954  0.92
1998 Harvey RJ, Whitehouse PJ, Rossor MN. Report of the European Working Group on Dementia Drug Guidelines Meeting--Brussels, November 1997. Alzheimer Disease and Associated Disorders. 12: 259-61. PMID 9876953  0.92
1998 Karlawish JH, Whitehouse PJ. Is the placebo control obsolete in a world after donepezil and vitamin E? Archives of Neurology. 55: 1420-4. PMID 9823825  0.92
1998 Whitehouse PJ. The cholinergic deficit in Alzheimer's disease. The Journal of Clinical Psychiatry. 59: 19-22. PMID 9771826  0.92
1998 Post SG, Whitehouse PJ. Emerging antidementia drugs: a preliminary ethical view. Journal of the American Geriatrics Society. 46: 784-7. PMID 9625200  0.92
1998 Smith AL, Whitehouse PJ. Progress in the management of Alzheimer's disease. Hospital Practice (1995). 33: 151-4, 157-66. PMID 9522840  0.92
1998 Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, Smith MA, Perry G, Whitehouse PJ, Taniguchi T. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Research. 780: 260-9. PMID 9507158 DOI: 10.1016/S0006-8993(97)01202-X  0.92
1998 Koss E, Patterson MB, Mack JL, Smyth KA, Whitehouse PJ. Reliability and validity of the Tinkertoy test in evaluating individuals with Alzheimer's disease Clinical Neuropsychologist. 12: 325-329. DOI: 10.1076/clin.12.3.325.1987  0.92
1998 Whitehouse PJ. An update on international harmonization concerning drug development in Alzheimer disease in memory of Professor Luigi Amaducci Alzheimer Disease and Associated Disorders. 12: 255-256.  0.92
1998 Brummel-Smith K, Rubenstein LZ, Whitehouse PJ. A practical guide to screening and assessment Patient Care. 32: 31-67.  0.92
1998 Whitehouse PJ. Long Term Care and Dementia Keio Journal of Medicine. 47: A43-A46.  0.92
1998 Van Potter R, Whitehouse PJ. Deep and global bioethics for a livable third millennium Scientist. 12.  0.92
1997 Whitehouse PJ. Readdressing our moral relationship to nonhuman creatures: commentary on "A dialogue on species-specific rights: humans and animals in bioethics. Cambridge Quarterly of Healthcare Ethics : Cq : the International Journal of Healthcare Ethics Committees. 6: 445-8. PMID 11644960  0.92
1997 Smyth KA, Ferris SH, Fox P, Heyman A, Holmes D, Morris JN, Phillips CD, Schulz R, Teresi J, Whitehouse PJ. Measurement choices in multi-site studies of outcomes in dementia. Alzheimer Disease and Associated Disorders. 11: 30-44. PMID 9437446  0.92
1997 Hay JW, Sano M, Whitehouse PJ. The costs and social burdens of Alzheimer disease: what can and should be done? Alzheimer Disease and Associated Disorders. 11: 181-3. PMID 9437434  0.92
1997 Whitehouse PJ. Pharmacoeconomics of dementia. Alzheimer Disease and Associated Disorders. 11: S22-32; discussion S. PMID 9348424  0.92
1997 Geldmacher DS, Lerner AJ, Voci JM, Noelker EA, Somple LC, Whitehouse PJ. Treatment of functional decline in adults with Down syndrome using selective serotonin-reuptake inhibitor drugs. Journal of Geriatric Psychiatry and Neurology. 10: 99-104. PMID 9322131  0.92
1997 Tracy KB. Genetic testing for Alzheimer disease. Jama. 278: 978-9. PMID 9307340  0.92
1997 Whitehouse PJ, Orgogozo JM, Becker RE, Gauthier S, Pontecorvo M, Erzigkeit H, Rogers S, Mohs RC, Bodick N, Bruno G, Dal-Bianco P. Quality-of-life assessment in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Disease and Associated Disorders. 11: 56-60. PMID 9305519  0.92
1997 Harvey RJ, Sciulli CG, Mason RM, Whitehouse PJ. Information technology and the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Disease and Associated Disorders. 11: 29-32. PMID 9305512  0.92
1997 Post SG, Beerman B, Brodaty H, Gaines AW, Gauthier SG, Geldmacher DS, Hill S, Homma A, Rossor MN, Whitehouse PJ, Winblad B. Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Disease and Associated Disorders. 11: 26-8. PMID 9305511  0.92
1997 Whitehouse PJ. The International Working Group on Harmonization of Dementia Drug Guidelines: past, present, and future. Alzheimer Disease and Associated Disorders. 11: 2-5. PMID 9305506  0.92
1997 Koss E, Weiner M, Ernesto C, Cohen-Mansfield J, Ferris SH, Grundman M, Schafer K, Sano M, Thal LJ, Thomas R, Whitehouse PJ. Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S45-50. PMID 9236952  0.92
1997 Patterson MB, Mack JL, Mackell JA, Thomas R, Tariot P, Weiner M, Whitehouse PJ. A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S40-4. PMID 9236951  0.92
1997 Ferris SH, Mackell JA, Mohs R, Schneider LS, Galasko D, Whitehouse PJ, Schmitt FA, Sano M, Thomas RG, Ernesto C, Grundman M, Schafer K, Thal LJ. A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S1-12. PMID 9236947  0.92
1997 Whitehouse PJ, Juengst E, Mehlman M, Murray TH. Enhancing cognition in the intellectually intact. The Hastings Center Report. 27: 14-22. PMID 9219019  0.92
1997 Sehgal AR, Grey SF, DeOreo PB, Whitehouse PJ. Prevalence, recognition, and implications of mental impairment among hemodialysis patients. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 30: 41-9. PMID 9214400  0.92
1997 Whitehouse PJ, Reidenbach F. Guidelines for early identification of Alzheimer Disease. Alzheimer Disease and Associated Disorders. 11: 61-2. PMID 9194951  0.92
1997 Whitehouse PJ. Genesis of Alzheimer's disease. Neurology. 48: S2-7. PMID 9153160  0.92
1997 Geldmacher DS, Whitehouse PJ. Differential diagnosis of Alzheimer's disease. Neurology. 48: S2-9. PMID 9153154  0.92
1997 Whitehouse PJ, Sciulli CG, Mason RM. Dementia drug development: use of information systems to harmonize global drug development. Psychopharmacology Bulletin. 33: 129-33. PMID 9133764  0.92
1997 Post SG, Whitehouse PJ, Binstock RH, Bird TD, Eckert SK, Farrer LA, Fleck LM, Gaines AD, Juengst ET, Karlinsky H, Miles S, Murray TH, Quaid KA, Relkin NR, Roses AD, et al. The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective. Jama. 277: 832-6. PMID 9052715  0.92
1997 Leber P, Post SG, Green RC, Whitehouse PJ, Rabins PV, Liebler ET, Rogers J, Malfliet TOT. General discussion Alzheimer Disease and Associated Disorders. 11: S37-S39.  0.92
1996 Whitehouse PJ, Patterson MB, Strauss ME, Geldmacher DS, Mack JL, Gilmore GC, Koss E. Hallucinations. International Psychogeriatrics / Ipa. 8: 387-92. PMID 9154594 DOI: 10.1017/S1041610297003694  0.92
1996 Roses AD, Saunders AM. Evaluation of suspected dementia. The New England Journal of Medicine. 335: 1996; author reply 1. PMID 8975127 DOI: 10.1056/NEJM199612263352613  0.92
1996 Whitehouse PJ, Post SG, Sachs GA. Dementia care at the end of life: empirical research and international collaboration. Alzheimer Disease and Associated Disorders. 10: 3-4. PMID 8919490 DOI: 10.1097/00002093-199601010-00002  0.92
1996 Whitehouse PJ, Morris JC. Disclosure of financial interest: a new policy for Alzheimer disease and associated disorders. Alzheimer Disease and Associated Disorders. 10: 1-2. PMID 8919489 DOI: 10.1097/00002093-199601010-00001  0.92
1996 Whitehouse PJ. Future prospects for Alzheimer's disease therapy: ethical and policy issues for the international community. Acta Neurologica Scandinavica. Supplementum. 165: 145-9. PMID 8741002 DOI: 10.1111/j.1600-0404.1996.tb05885.x  0.92
1996 Ku Y, Whitehouse PJ. Complementary therapeutic alternatives: what can we learn? Alzheimer Disease and Associated Disorders. 10: 61-2. PMID 8727165 DOI: 10.1097/00002093-199601020-00001  0.92
1996 Geldmacher DS, Whitehouse PJ. Evaluation of dementia. The New England Journal of Medicine. 335: 330-6. PMID 8663868 DOI: 10.1056/NEJM199608013350507  0.92
1996 Ferris SH, Whitehouse PJ. Advances in drug development: The role of Alzheimer Disease and Associated Disorders Alzheimer Disease and Associated Disorders. 10: 121.  0.92
1996 Patterson MB, Mack JL, Geldmacher DS, Whitehouse PJ. Executive functions and Alzheimer's disease: Problems and prospects European Journal of Neurology. 3: 5-15.  0.92
1995 Shimohama S, Fujimoto S, Chachin M, Taniguchi T, Perry G, Whitehouse PJ, Kimura J. Alterations of low molecular weight acid phosphatase protein level in Alzheimer's disease. Brain Research. 699: 125-9. PMID 8616601 DOI: 10.1016/0006-8993(95)00995-3  0.92
1995 Whitehouse PJ, Kalaria RN. Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications. Alzheimer Disease and Associated Disorders. 9: 3-5. PMID 8534421  0.92
1995 Ripich DN, Petrill SA, Whitehouse PJ, Ziol EW. Gender differences in language of AD patients: a longitudinal study. Neurology. 45: 299-302. PMID 7854529  0.92
1995 Shimohama S, Fujimoto S, Matsushima H, Takenawa T, Taniguchi T, Perry G, Whitehouse PJ, Kimura J. Alteration of phospholipase C-delta protein level and specific activity in Alzheimer's disease. Journal of Neurochemistry. 64: 2629-34. PMID 7760043  0.92
1995 Gilmore GC, Whitehouse PJ. Contrast sensitivity in Alzheimer's disease: a 1-year longitudinal analysis. Optometry and Vision Science : Official Publication of the American Academy of Optometry. 72: 83-91. PMID 7753532  0.92
1995 Shimohama S, Perry G, Richey P, Praprotnik D, Takenawa T, Fukami K, Whitehouse PJ, Kimura J. Characterization of the association of phospholipase C-delta with Alzheimer neurofibrillary tangles. Brain Research. 669: 217-24. PMID 7712177 DOI: 10.1016/0006-8993(94)01239-E  0.92
1995 Whitehouse PJ, Deal WE. Situated beyond modernity: lessons for Alzheimer's disease research. Journal of the American Geriatrics Society. 43: 1314-5. PMID 7594171 DOI: 10.1111/j.1532-5415.1995.tb07413.x  0.92
1995 Whitehouse PJ, Voci J. Therapeutic trials in Alzheimer's disease. Current Opinion in Neurology. 8: 275-8. PMID 7582042  0.92
1995 Whitehouse PJ. Should we differentiate subtypes of Alzheimer disease? Alzheimer Disease and Associated Disorders. 9: S1. PMID 7546593  0.92
1995 Post SG, Whitehouse PJ. Fairhill guidelines on ethics of the care of people with Alzheimer's disease: a clinical summary. Center for Biomedical Ethics, Case Western Reserve University and the Alzheimer's Association. Journal of the American Geriatrics Society. 43: 1423-9. PMID 7490397  0.92
1995 Ferris SH, Hasegawa K, Homma A, Khachaturian ZS, Post S, Rossor M, Whitehouse PJ. International efforts to improve Alzheimer disease treatment Alzheimer Disease and Associated Disorders. 9: 181.  0.92
1994 Post SG, Ripich DN, Whitehouse PJ. Discourse ethics: research, dementia, and communication. Alzheimer Disease and Associated Disorders. 8: 58-65. PMID 11657675  0.92
1994 High DM, Post SG, Whitehouse PJ. Introduction (to 6 articles and a position paper on ethical and legal issues in Alzheimer disease research) Alzheimer Disease and Associated Disorders. 8: 1-4. PMID 11657669  0.92
1994 Martin RJ, Gwyther LP, Whitehouse PJ. Special care unit research: ethical issues. Alzheimer Disease and Associated Disorders. 8: S360-7. PMID 11657168  0.92
1994 Lerner AJ, Koss E, Patterson MB, Ownby RL, Hedera P, Friedland RP, Whitehouse PJ. Concomitants of visual hallucinations in Alzheimer's disease. Neurology. 44: 523-7. PMID 8145925  0.92
1994 Levy R, Howard RJ, Richards M, Amaducci LA, Derouesne C, Hofman A, Huppert F, Rabins PV, Raptopoulos P, Ustun B, Whitehouse PJ. Aging-associated cognitive decline International Psychogeriatrics. 6: 63-68. PMID 8054494 DOI: 10.1017/S1041610294001626  0.92
1994 Whitehouse PJ, Geldmacher DS. Pharmacotherapy for Alzheimer's disease. Clinics in Geriatric Medicine. 10: 339-50. PMID 8039102  0.92
1994 Patterson MB, Whitehouse PJ. Behavioral symptoms in dementia: theories and therapies. Alzheimer Disease and Associated Disorders. 8: 1-3. PMID 7999336  0.92
1994 Dresser R, Whitehouse PJ. The incompetent patient on the slippery slope. The Hastings Center Report. 24: 6-12. PMID 7960711  0.92
1994 Lanska DJ, Currier RD, Cohen M, Gambetti P, Smith EE, Bebin J, Jackson JF, Whitehouse PJ, Markesbery WR. Familial progressive subcortical gliosis. Neurology. 44: 1633-43. PMID 7936288  0.92
1994 Kalaria RN, Homayoun P, Whitehouse PJ. Nicotinic cholinergic receptors associated with mammalian cerebral vessels. Journal of the Autonomic Nervous System. 49: S3-7. PMID 7836682 DOI: 10.1016/0165-1838(94)90078-7  0.92
1994 Ownby RL, Koss E, Smyth KA, Whitehouse PJ. The factor structure of the Brief Psychiatric Rating Scale in Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology. 7: 245-50. PMID 7826495 DOI: 10.1177/089198879400700410  0.92
1994 High DM, Whitehouse PJ, Post SG, Berg L. Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper. National Institute on Aging. Alzheimer Disease and Associated Disorders. 8: 66-74. PMID 7695858 DOI: 10.1097/00002093-199400000-00008  0.92
1994 High DM, Post SG, Whitehouse PJ. Ethical and legal issues in Alzheimer disease research. Introduction. Alzheimer Disease and Associated Disorders. 8: 1-4. PMID 7695851  0.92
1994 High DM, Post SG, Whitehouse PJ. Advancing Research with Alzheimer Disease Subjects: Ethical and Legal Issues, Washington, D.C., USA, November 6, 1993: Introduction Alzheimer Disease and Associated Disorders. 8: 1-4.  0.92
1994 Whitehouse PJ. Alzheimer's disease: Treatments on the horizon P and T. 19: 153-155+159-160+164-.  0.92
1994 Whitehouse PJ. Introduction: National Institute on Aging Special Care Units Alzheimer Disease and Associated Disorders. 8: S1.  0.92
1993 Celesia GG, Breuer AC, Goldblatt D, Rottenberg DA, Saper CB, Scneck SA, Schutta H, Trauner DA, Whitehouse PJ. Persistent vegetative state: Report of the American Neurological Association Committee on Ethical Affairs Annals of Neurology. 33: 386-390. PMID 8489209  0.92
1993 Koss E, Patterson MB, Ownby R, Stuckey JC, Whitehouse PJ. Memory evaluation in Alzheimer's disease. Caregivers' appraisals and objective testing. Archives of Neurology. 50: 92-7. PMID 8418807 DOI: 10.1001/archneur.1993.00540010086023  0.92
1993 Whitehouse PJ. Autopsy. The Gerontologist. 33: 436-7. PMID 8375668  0.92
1993 Mack JL, Patterson MB, Schnell AH, Whitehouse PJ. Performance of subjects with probable Alzheimer disease and normal elderly controls on the Gollin Incomplete Pictures Test. Perceptual and Motor Skills. 77: 951-69. PMID 8284183 DOI: 10.2466/pms.1993.77.3.951  0.92
1993 Kennedy JS, Strauss ME, Smyth KA, Whitehouse PJ. The relationship of clinical psychopathologic rating and cognitive factors to clinical dementia staging. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 17: 775-9. PMID 8255985 DOI: 10.1016/0278-5846(93)90059-2  0.92
1993 Shimohama S, Fujimoto S, Tresser N, Richey P, Perry G, Whitehouse PJ, Homma Y, Takenawa T, Taniguchi T, Suenaga T. Aberrant phosphoinositide metabolism in Alzheimer's disease. Annals of the New York Academy of Sciences. 695: 46-9. PMID 8239311 DOI: 10.1111/j.1749-6632.1993.tb23025.x  0.92
1993 Whitehouse PJ, Landreth G, Younkin S. Molecular biology of Alzheimer's disease. Molecular Genetic Medicine. 3: 95-137. PMID 8220165  0.92
1993 Whitehouse PJ. Cholinergic therapy in dementia. Acta Neurologica Scandinavica. Supplementum. 149: 42-5. PMID 8128838  0.92
1993 Shimohama S, Perry G, Richey P, Takenawa T, Whitehouse PJ, Miyoshi K, Suenaga T, Matsumoto S, Nishimura M, Kimura J. Abnormal accumulation of phospholipase C-delta in filamentous inclusions of human neurodegenerative diseases. Neuroscience Letters. 162: 183-6. PMID 8121625 DOI: 10.1016/0304-3940(93)90591-8  0.92
1992 Mendez MF, Martin RJ, Smyth KA, Whitehouse PJ. Disturbances of person identification in Alzheimer's disease. A retrospective study. The Journal of Nervous and Mental Disease. 180: 94-6. PMID 1737981  0.92
1992 Chatterjee A, Strauss ME, Smyth KA, Whitehouse PJ. Personality changes in Alzheimer's disease. Archives of Neurology. 49: 486-91. PMID 1580810 DOI: 10.1001/archneur.1992.00530290070014  0.92
1992 Patterson MB, Mack JL, Neundorfer MM, Martin RJ, Smyth KA, Whitehouse PJ. Assessment of functional ability in Alzheimer disease: a review and a preliminary report on the Cleveland Scale for Activities of Daily Living. Alzheimer Disease and Associated Disorders. 6: 145-63. PMID 1485930  0.92
1992 Whitehouse PJ, Rabins PV. Quality of life and dementia. Alzheimer Disease and Associated Disorders. 6: 135-7. PMID 1485928  0.92
1992 Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, Drachman DA, Schneider LS, Whitehouse PJ, Hoover TM. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. The New England Journal of Medicine. 327: 1253-9. PMID 1406817 DOI: 10.1056/NEJM199210293271801  0.92
1992 Patterson MB, Whitehouse PJ. Behavioral symptoms in Alzheimer disease: a look ahead. Alzheimer Disease and Associated Disorders. 6: 71-2. PMID 1389081  0.92
1992 Lerner AJ, Friedland RP, Whitehouse PJ. Uses of biological markers. Alzheimer Disease and Associated Disorders. 6: 197-200. PMID 1290622  0.92
1992 Kennedy JS, Whitehouse PJ. 12-Month trial of acetyl-L-carnitine for Alzheimer disease Annals of Internal Medicine. 116: 81.  0.92
1990 Wagster MV, Whitehouse PJ, Walker LC, Kellar KJ, Price DL. Laminar organization and age-related loss of cholinergic receptors in temporal neocortex of rhesus monkey. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 2879-85. PMID 2398366  0.92
1990 Patterson MB, Schnell AH, Martin RJ, Mendez MF, Smyth KA, Whitehouse PJ. Assessment of behavioral and affective symptoms in Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology. 3: 21-30. PMID 2346584  0.92
1990 Mendez MF, Mendez MA, Martin R, Smyth KA, Whitehouse PJ. Complex visual disturbances in Alzheimer's disease. Neurology. 40: 439-43. PMID 2314585  0.92
1990 Mendez MF, Martin RJ, Smyth KA, Whitehouse PJ. Psychiatric symptoms associated with Alzheimer's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 2: 28-33. PMID 2136060  0.92
1990 Palmert MR, Podlisny MB, Golde TE, Cohen ML, Kovacs DM, Tanzi RE, Gusella JF, Whitehouse PJ, Witker DS, Oltersdorf T. Analysis of the beta-amyloid protein precursor of Alzheimer's disease: mRNAs and protein products. Advances in Neurology. 51: 181-4. PMID 2104687  0.92
1989 Powers RE, Powell SK, Schlough CN, Whitehouse PJ. Autopsy services for dementia patients. The Gerontologist. 29: 120-3. PMID 2753369  0.4
1989 Atack JR, Wenk GL, Wagster MV, Kellar KJ, Whitehouse PJ, Rapoport SI. Bilateral changes in neocortical [3H]pirenzepine and [3H]oxotremorine-M binding following unilateral lesions of the rat nucleus basalis magnocellularis: an autoradiographic study. Brain Research. 483: 367-72. PMID 2706526 DOI: 10.1016/0006-8993(89)90182-0  0.92
1989 Teng EL, Wimer C, Roberts E, Damasio AR, Eslinger PJ, Folstein MF, Tune LE, Whitehouse PJ, Bardolph EL, Chui HC. Alzheimer's dementia: performance on parallel forms of the dementia assessment battery. Journal of Clinical and Experimental Neuropsychology. 11: 899-912. PMID 2687312 DOI: 10.1080/01688638908400943  0.92
1989 Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, Folstein MF, Price DL. Neuropathology of aminergic nuclei in Alzheimer's disease. Progress in Clinical and Biological Research. 317: 353-65. PMID 2602423  0.72
1989 Whitehouse PJ, Gambetti P, Harik SI, Kalaria RN, Perry G, Younkin SI, Tabaton M, Unnerstall JR. Neurochemistry of dementia: establishing the links. Progress in Clinical and Biological Research. 317: 131-42. PMID 2574868  0.92
1989 Kalaria RN, Andorn AC, Tabaton M, Whitehouse PJ, Harik SI, Unnerstall JR. Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus. Journal of Neurochemistry. 53: 1772-81. PMID 2553864  0.92
1989 Palmert MR, Podlisny MB, Golde TE, Cohen ML, Kovacs DM, Tanzi RE, Gusella JF, Whitehouse PJ, Witker DS, Oltersdorf T. The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives. Progress in Clinical and Biological Research. 317: 971-84. PMID 2513588  0.92
1988 Whitehouse PJ, Martino AM, Marcus KA, Zweig RM, Singer HS, Price DL, Kellar KJ. Reductions in acetylcholine and nicotine binding in several degenerative diseases. Archives of Neurology. 45: 722-4. PMID 3390025 DOI: 10.1001/archneur.1988.00520310028012  0.92
1988 Whitehouse PJ, Martino AM, Wagster MV, Price DL, Mayeux R, Atack JR, Kellar KJ. Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology. 38: 720-3. PMID 3362368  0.92
1988 Zweig RM, Hedreen JC, Jankel WR, Casanova MF, Whitehouse PJ, Price DL. Pathology in brainstem regions of individuals with primary dystonia. Neurology. 38: 702-6. PMID 3362365  0.72
1988 Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, Folstein MF, Price DL. The neuropathology of aminergic nuclei in Alzheimer's disease. Annals of Neurology. 24: 233-42. PMID 3178178 DOI: 10.1002/ana.410240210  0.72
1988 Tabaton M, Whitehouse PJ, Perry G, Davies P, Autilio-Gambetti L, Gambetti P. Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy. Annals of Neurology. 24: 407-13. PMID 3067653 DOI: 10.1002/ana.410240309  0.92
1988 Casanova MF, Struble RG, Whitehouse PJ, Price DL. A historical perspective on the neuropathology of dementia with emphasis on the senile plaque. BoletíN De La AsociacióN MéDica De Puerto Rico. 80: 424-8. PMID 3064761  0.72
1988 Hedreen JC, Zweig RM, DeLong MR, Whitehouse PJ, Price DL. Primary dystonias: a review of the pathology and suggestions for new directions of study. Advances in Neurology. 50: 123-32. PMID 3041757  0.92
1988 Whitehouse PJ, Unnerstall JR. Neurochemistry of dementia. European Neurology. 28: 36-41. PMID 2967756  0.92
1987 Kellar KJ, Whitehouse PJ, Martino-Barrows AM, Marcus K, Price DL. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex. Brain Research. 436: 62-8. PMID 3690354 DOI: 10.1016/0006-8993(87)91556-3  0.92
1987 Zweig RM, Whitehouse PJ, Casanova MF, Walker LC, Jankel WR, Price DL. Loss of pedunculopontine neurons in progressive supranuclear palsy. Annals of Neurology. 22: 18-25. PMID 3631916 DOI: 10.1002/ana.410220107  0.72
1987 Wand GS, May C, May V, Whitehouse PJ, Rapoport SI, Eipper BA. Alzheimer's disease: low levels of peptide alpha-amidation activity in brain and CSF. Neurology. 37: 1057-61. PMID 3587629  0.92
1987 Price DL, Cork LC, Struble RG, Kitt CA, Walker LC, Powers RE, Whitehouse PJ, Griffin JW. Dysfunction and death of neurons in human degenerative neurological diseases and in animal models. Ciba Foundation Symposium. 126: 30-48. PMID 3556088  0.72
1987 Powers RE, Walker LC, DeSouza EB, Vale WW, Struble RG, Whitehouse PJ, Price DL. Immunohistochemical study of neurons containing corticotropin-releasing factor in Alzheimer's disease. Synapse (New York, N.Y.). 1: 405-10. PMID 3509803 DOI: 10.1002/syn.890010504  0.92
1987 De Souza EB, Whitehouse PJ, Price DL, Vale WW. Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disorders. Annals of the New York Academy of Sciences. 512: 237-47. PMID 3502064  0.72
1987 Whitehouse PJ, Vale WW, Zweig RM, Singer HS, Mayeux R, Kuhar MJ, Price DL, De Souza EB. Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy. Neurology. 37: 905-9. PMID 3495748  0.72
1987 D'Amato RJ, Zweig RM, Whitehouse PJ, Wenk GL, Singer HS, Mayeux R, Price DL, Snyder SH. Aminergic systems in Alzheimer's disease and Parkinson's disease. Annals of Neurology. 22: 229-36. PMID 3477996 DOI: 10.1002/ana.410220207  0.92
1987 Trifiletti RR, Snowman AM, Whitehouse PJ, Marcus KA, Snyder SH. Huntington's disease: increased number and altered regulation of benzodiazepine receptor complexes in frontal cerebral cortex. Neurology. 37: 916-22. PMID 3035427  0.92
1987 Whitehouse PJ, Kellar KJ. Nicotinic and muscarinic cholinergic receptors in Alzheimer's disease and related disorders. Journal of Neural Transmission. Supplementum. 24: 175-82. PMID 2960781  0.92
1987 De Souza EB, Whitehouse PJ, Folstein SE, Price DL, Vale WW. Corticotropin-releasing hormone (CRH) is decreased in the basal ganglia in Huntington's disease. Brain Research. 437: 355-9. PMID 2893655  0.72
1987 Unnerstall JR, Whitehouse PJ. New approaches to quantitative neuropathology: multivariate analysis of morphologic and neurochemical measures. Neurobiology of Aging. 8: 567-9. PMID 2893305 DOI: 10.1016/0197-4580(87)90138-2  0.92
1986 Clark AW, White CL, Manz HJ, Parhad IM, Curry B, Whitehouse PJ, Lehmann J, Coyle JT. Primary degenerative dementia without Alzheimer pathology. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 13: 462-70. PMID 3791063 DOI: 10.1017/S0317167100037136  0.92
1986 Whitehouse PJ, Martino AM, Antuono PG, Lowenstein PR, Coyle JT, Price DL, Kellar KJ. Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Research. 371: 146-51. PMID 3708340 DOI: 10.1016/0006-8993(86)90819-X  0.92
1986 Price DL, Struble RG, Whitehouse PJ, Kitt CA, Cork LC, Walker LC, Casanova MF. Alzheimer's disease: a multisystem disorder. Research Publications - Association For Research in Nervous and Mental Disease. 64: 209-14. PMID 3523660  0.72
1986 De Souza EB, Whitehouse PJ, Kuhar MJ, Price DL, Vale WW. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease. Nature. 319: 593-5. PMID 3003585 DOI: 10.1038/319593a0  0.72
1985 Batshaw ML, Wachtel RC, Deckel AW, Whitehouse PJ, Moses H, Fochtman LJ, Eldridge R. Munchausen's syndrome simulating torsion dystonia. The New England Journal of Medicine. 312: 1437-9. PMID 3990745 DOI: 10.1056/NEJM198505303122207  0.92
1985 Price DL, Cork LC, Struble RG, Whitehouse PJ, Kitt CA, Walker LC. The functional organization of the basal forebrain cholinergic system in primates and the role of this system in Alzheimer's disease. Annals of the New York Academy of Sciences. 444: 287-95. PMID 3160283  0.72
1985 Whitehouse PJ, Trifiletti RR, Jones BE, Folstein S, Price DL, Snyder SH, Kuhar MJ. Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes. Annals of Neurology. 18: 202-10. PMID 2994554 DOI: 10.1002/ana.410180207  0.92
1985 Whitehouse PJ, Wamsley JK, Zarbin MA, Price DL, Kuhar MJ. Neurotransmitter receptors in amyotrophic lateral sclerosis: possible relationship to sparing of eye movements. Annals of Neurology. 17: 518. PMID 2988415 DOI: 10.1002/ana.410170518  0.72
1985 Casanova MF, Walker LC, Whitehouse PJ, Price DL. Abnormalities of the nucleus basalis in Down's syndrome. Annals of Neurology. 18: 310-3. PMID 2932050 DOI: 10.1002/ana.410180306  0.72
1985 Whitehouse PJ, Struble RG, Hedreen JC, Clark AW, Price DL. Alzheimer's disease and related dementias: selective involvement of specific neuronal systems. Crc Critical Reviews in Clinical Neurobiology. 1: 319-39. PMID 2876845  0.92
1985 Price DL, Kitt CA, Struble RG, Whitehouse PJ, Cork LC, Walker LC. Neurobiological studies of transmitter systems in aging and in Alzheimer-type dementia. Annals of the New York Academy of Sciences. 457: 35-51. PMID 2869729  0.72
1985 Price DL, Whitehouse PJ, Struble RG. Alzheimer's disease. Annual Review of Medicine. 36: 349-56. PMID 2859830 DOI: 10.1146/annurev.me.36.020185.002025  0.72
1984 Whitehouse PJ, Lynch D, Kuhar MJ. Effects of postmortem delay and temperature on neurotransmitter receptor binding in a rat model of the human autopsy process. Journal of Neurochemistry. 43: 553-9. PMID 6330303  0.92
1984 Hedreen JC, Struble RG, Whitehouse PJ, Price DL. Topography of the magnocellular basal forebrain system in human brain. Journal of Neuropathology and Experimental Neurology. 43: 1-21. PMID 6319616  0.72
1984 Uhl GR, Whitehouse PJ, Price DL, Tourtelotte WW, Kuhar MJ. Parkinson's disease: depletion of substantia nigra neurotensin receptors. Brain Research. 308: 186-90. PMID 6089953  0.72
1983 Whitehouse PJ, Hedreen JC, White CL, Price DL. Basal forebrain neurons in the dementia of Parkinson disease. Annals of Neurology. 13: 243-8. PMID 6847136 DOI: 10.1002/ana.410130304  0.72
1983 Uhl GR, Hilt DC, Hedreen JC, Whitehouse PJ, Price DL. Pick's disease (lobar sclerosis): depletion of neurons in the nucleus basalis of Meynert. Neurology. 33: 1470-3. PMID 6685239  0.72
1983 Whitehouse PJ, Struble RG, Hedreen JC, Clark AW, White CL, Parhad IM, Price DL. Neuroanatomical evidence for a cholinergic deficit in Alzheimer's disease. Psychopharmacology Bulletin. 19: 437-40. PMID 6635120  0.72
1983 Folstein MF, Whitehouse PJ. Cognitive impairment of Alzheimer disease. Neurobehavioral Toxicology and Teratology. 5: 631-4. PMID 6366602  0.44
1983 Clark AW, Parhad IM, Folstein SE, Whitehouse PJ, Hedreen JC, Price DL, Chase GA. The nucleus basalis in Huntington's disease. Neurology. 33: 1262-7. PMID 6225032  0.92
1983 Whitehouse PJ, Wamsley JK, Zarbin MA, Price DL, Tourtellotte WW, Kuhar MJ. Amyotrophic lateral sclerosis: alterations in neurotransmitter receptors. Annals of Neurology. 14: 8-16. PMID 6137185 DOI: 10.1002/ana.410140103  0.72
1982 Whitehouse PJ, Struble RG, Clark AW, Price DL. Alzheimer disease: plaques, tangles, and the basal forebrain. Annals of Neurology. 12: 494. PMID 7181455 DOI: 10.1002/ana.410120517  0.92
1982 Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science (New York, N.Y.). 215: 1237-9. PMID 7058341  0.92
1982 Struble RG, Cork LC, Whitehouse PJ, Price DL. Cholinergic innervation in neuritic plaques. Science (New York, N.Y.). 216: 413-5. PMID 6803359  0.72
1982 Price DL, Whitehouse PJ, Struble RG, Coyle JT, Clark AW, Delong MR, Cork LC, Hedreen JC. Alzheimer's disease and Down's syndrome. Annals of the New York Academy of Sciences. 396: 145-64. PMID 6217772  0.72
1981 Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Annals of Neurology. 10: 122-6. PMID 7283399 DOI: 10.1002/ana.410100203  0.92
Show low-probability matches.